Simple Summary The aim of this review is to evaluate the different approaches to early-stage hepatocellular carcinoma according to Western and Eastern interventional radiology perspectives based on the most recent literature. Understanding different perspectives and guidelines can help in selecting the correct indication of locoregional procedures (mostly ablation, chemoembolization, and radioembolization) for every patient. Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.
Iezzi, R., Posa, A., Contegiacomo, A., Lee, I. J., Bale, R., Tanzilli, A., Tenore, L., Giuliante, F., Gasbarrini, A., Goldberg, S. N., Jakobs, T., Pompili, M., Bargellini, I., Sala, E., Kim, H., Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives, <<CANCERS>>, N/A; 15 (15): N/A-N/A. [doi:10.3390/cancers15153988] [https://hdl.handle.net/10807/292318]
Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
Iezzi, Roberto;Posa, Alessandro;Contegiacomo, Andrea;Tenore, Lorenzo;Giuliante, Felice;Gasbarrini, Antonio;Pompili, Maurizio;Bargellini, Irene;Sala, Evis;
2023
Abstract
Simple Summary The aim of this review is to evaluate the different approaches to early-stage hepatocellular carcinoma according to Western and Eastern interventional radiology perspectives based on the most recent literature. Understanding different perspectives and guidelines can help in selecting the correct indication of locoregional procedures (mostly ablation, chemoembolization, and radioembolization) for every patient. Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.